tirzepatide compounding deadline Zepbound No Longer in Shortage: What This Means for Compounded tirzepatide compound deadline Compounded medications

The end of the shortage would effectively bar the sale of compounded versions of the drugs, but the FDA said that they do not plan to take any action against compounding pharmacies for 60 to 90 days

How GLP-1 Drugs Influence Blood Pressure in the Body The way GLP-1 therapies influence blood pressure is complex but fascinating

The market is fast-moving and any unexpected competition may radically alter dynamics in the private market

David Hunter, MD, an associate professor of neurology at UTHealth Houston, not involved in this review, spoke with Medical News Today about its findings

SOURCE: FDA, news release, Dec